Biomolecules & Therapeutics : eISSN 2005-4483 / pISSN 1976-9148

Download original image
Fig. 4. LCH inhibits the expression of active form p-EGFR and p-AKT kinases. (A) Cells were treated with LCH at the indicated concentration for 48 h, then the protein levels were determined by Western blotting against phospho (p)-EGFR (Tyr1068), EGFR, p-AKT (Ser473), AKT antibodies. Actin was used as an internal control for equal loading. (B, C) Quantitation of active form p-EGFR and p-AKT compared to each total form. **p<0.01 and ***p<0.001 compared with the control.
Biomolecules & Therapeutics 2023;31:661~673
© Biomolecules & Therapeutics